vs
Enact Holdings, Inc.（ACT）与Inspire Medical Systems, Inc.（INSP）财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是Inspire Medical Systems, Inc.的1.5倍（$312.1M vs $204.6M），Enact Holdings, Inc.同比增速更快（1.7% vs 1.6%），过去两年Inspire Medical Systems, Inc.的营收复合增速更高（2.2% vs 2.2%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
Inspire Medical Systems是一家专注于阻塞性睡眠呼吸暂停治疗的医疗科技企业，研发、生产并销售植入式神经刺激设备，面向无法耐受持续气道正压通气治疗的患者，核心市场覆盖北美、欧洲及部分亚太地区，服务睡眠医学、耳鼻喉科等临床领域。
ACT vs INSP — 直观对比
营收规模更大
ACT
是对方的1.5倍
$204.6M
营收增速更快
ACT
高出0.1%
1.6%
两年增速更快
INSP
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $312.1M | $204.6M |
| 净利润 | $168.0M | — |
| 毛利率 | — | 86.5% |
| 营业利润率 | — | 13.0% |
| 净利率 | 53.8% | — |
| 营收同比 | 1.7% | 1.6% |
| 净利润同比 | 1.2% | — |
| 每股收益（稀释后） | $1.18 | $-0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTINSP
| Q1 26 | $312.1M | $204.6M | ||
| Q4 25 | $312.7M | $269.1M | ||
| Q3 25 | $311.5M | $224.5M | ||
| Q2 25 | $304.9M | $217.1M | ||
| Q1 25 | $306.8M | $201.3M | ||
| Q4 24 | $301.8M | $239.7M | ||
| Q3 24 | $309.6M | $203.2M | ||
| Q2 24 | $298.8M | $195.9M |
净利润ACTINSP
| Q1 26 | $168.0M | — | ||
| Q4 25 | — | $136.1M | ||
| Q3 25 | — | $9.9M | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $18.5M | ||
| Q2 24 | — | $9.8M |
毛利率ACTINSP
| Q1 26 | — | 86.5% | ||
| Q4 25 | — | 86.6% | ||
| Q3 25 | — | 85.8% | ||
| Q2 25 | — | 84.0% | ||
| Q1 25 | — | 84.7% | ||
| Q4 24 | — | 85.0% | ||
| Q3 24 | — | 84.1% | ||
| Q2 24 | — | 84.8% |
营业利润率ACTINSP
| Q1 26 | — | 13.0% | ||
| Q4 25 | 71.3% | 17.1% | ||
| Q3 25 | 67.4% | 4.3% | ||
| Q2 25 | 70.4% | -1.5% | ||
| Q1 25 | 68.9% | -0.7% | ||
| Q4 24 | 68.9% | 13.3% | ||
| Q3 24 | 74.1% | 7.0% | ||
| Q2 24 | 78.6% | 2.6% |
净利率ACTINSP
| Q1 26 | 53.8% | — | ||
| Q4 25 | — | 50.6% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | — | 5.0% |
每股收益（稀释后）ACTINSP
| Q1 26 | $1.18 | $-0.39 | ||
| Q4 25 | $1.23 | $4.57 | ||
| Q3 25 | $1.10 | $0.34 | ||
| Q2 25 | $1.11 | $-0.12 | ||
| Q1 25 | $1.08 | $0.10 | ||
| Q4 24 | $1.05 | $1.17 | ||
| Q3 24 | $1.15 | $0.60 | ||
| Q2 24 | $1.16 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $549.0M | $98.9M |
| 总债务越低越好 | $744.9M | — |
| 股东权益账面价值 | $5.3B | $792.3M |
| 总资产 | $7.0B | $911.4M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTINSP
| Q1 26 | $549.0M | $98.9M | ||
| Q4 25 | $582.5M | $308.3M | ||
| Q3 25 | $545.6M | $322.6M | ||
| Q2 25 | $616.0M | $300.9M | ||
| Q1 25 | $639.0M | $369.2M | ||
| Q4 24 | $602.8M | $445.5M | ||
| Q3 24 | $674.9M | $411.0M | ||
| Q2 24 | $711.3M | $439.7M |
总债务ACTINSP
| Q1 26 | $744.9M | — | ||
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — |
股东权益ACTINSP
| Q1 26 | $5.3B | $792.3M | ||
| Q4 25 | $5.4B | $781.2M | ||
| Q3 25 | $5.3B | $666.5M | ||
| Q2 25 | $5.2B | $677.8M | ||
| Q1 25 | $5.1B | $635.7M | ||
| Q4 24 | $5.0B | $689.7M | ||
| Q3 24 | $5.0B | $696.6M | ||
| Q2 24 | $4.8B | $638.1M |
总资产ACTINSP
| Q1 26 | $7.0B | $911.4M | ||
| Q4 25 | $6.9B | $907.3M | ||
| Q3 25 | $6.9B | $807.7M | ||
| Q2 25 | $6.8B | $802.2M | ||
| Q1 25 | $6.7B | $730.8M | ||
| Q4 24 | $6.5B | $808.4M | ||
| Q3 24 | $6.6B | $796.2M | ||
| Q2 24 | $6.3B | $728.4M |
负债/权益比ACTINSP
| Q1 26 | 0.14× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
| Premiums | $242.8M | 78% |
| Other | $69.2M | 22% |
INSP
暂无分部数据
